Katiane R. Servelhere
Campinas, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Unraveling SPG46: Clinical, Genetic, and Neuroimaging Features.
Journal: Movement disorders clinical practice
Published: December 10, 2025
Ziclague® (Alpinia Zerumbet oil) in patients with hereditary spastic paraplegia - the randomized controlled ZISPAST trial.
Journal: Orphanet journal of rare diseases
Published: June 25, 2024
Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 21, 2020
Brain Damage and Gene Expression Across Hereditary Spastic Paraplegia Subtypes.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 12, 2020
Spinal Cord Gray and White Matter Damage in Different Hereditary Spastic Paraplegia Subtypes.
Journal: AJNR. American journal of neuroradiology
Published: May 22, 2020
Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.
Journal: Arquivos de neuro-psiquiatria
Published: May 31, 2017
Translation and validation into Brazilian Portuguese of the Spastic Paraplegia Rating Scale (SPRS).
Journal: Arquivos de neuro-psiquiatria
Published: December 04, 2015
Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations.
Journal: European journal of neurology
Published: April 13, 2015
Clinical features and management of hereditary spastic paraplegia.
Journal: Arquivos de neuro-psiquiatria
Published: August 30, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026